Livzon Pharmaceutical Group, Inc. Financials

Market Capitalization CN¥30.18 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	15.80
Forward PE	14.48
Price to Sales TTM	CN¥2.57
Price to Book MRQ	CN¥2.30
Enterprise to Revenue	2.25
Enterprise to EBITDA	8.53

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	17.79%
Operating Margin	27.02%
Return on Assets TTM	6.58%
Return on Equity TTM	15.53%

Income Statement

Revenue TTM	CN¥11,750,072,320
Revenue per Share TTM	CN¥12.90
Quarterly Revenue Growth	-1.90%
Gross Profit TTM	CN¥7,532,431,360
EBITDA	CN¥3,164,317,332
Net Income to Common TTM	CN¥2,089,979,904
Diluted EPS TTM	CN¥2.30
Quarterly Earnings Growth YoY	4.80%

Balance Sheet

Total Cash MRQ	CN¥10,899,094,528
Total Cash per Share MRQ	CN¥12.18
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	25.09
Current Ratio MRQ	2.28
Book Value per Share MRQ	CN¥15.83

Cash Flow

Operating Cash Flow TTM	CN¥2,779,329,536
Levered Free Cash Flow TTM	CN¥1,322,521,344

000513 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	911,345,730
Float Shares	461,804,124
Avg 10 Volume	7,974,734
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	43.17%
% Held by Institutions	12.31%

Stock Price Summary

Beta	0.34
Fifty Two Week Low	CN¥32.94
Fifty Two Week High	CN¥44.72
Fifty Two Week Change	1.18%
Day 50 MA	CN¥35.95
Day 200 MA	CN¥36.37

Dividends and Splits

Forward Annual Dividend Rate	CN¥4.40
Forward Annual Dividend Yield	12.11%
Trailing Annual Dividend Rate	CN¥1.10
Trailing Annual Dividend Yield	3.03%
Payout Ratio	58.70%
Dividend Date
Ex Dividend Date	2025-06-13
Last Split Factor
Last Split Date	2019-07-03